Esotropia Clinical Trial
Official title:
Prescription of Full Optical Correction in Refractive Errors to Treat Esotropia in Children up to 3 Years Old
Verified date | March 2015 |
Source | National Centre of Ophthalmology named after academician Zarifa Aliyeva |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this prospective study is the treatment of esotropia by prescribing the full precise optical correction of refractive errors in children up to 3 years old.
Status | Active, not recruiting |
Enrollment | 150 |
Est. completion date | November 2017 |
Est. primary completion date | October 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 3 Months to 3 Years |
Eligibility |
Inclusion Criteria: - Within the age of 3 months to 3 years (inclusive infantile esotropia) - Patients with constant or periodic esotropia and with revealed angle of deviation 5 degrees or over by Hirschberg test - Patients with refractive errors (inclusive minor ametropias from 0.5 Dptr) Exclusion Criteria: - Age above 3 years - Patients with neurological diseases and paralytic strabismus |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
National Centre of Ophthalmology named after academician Zarifa Aliyeva |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The angle of deviation | The absolute success is defined as restored symmetrical eye position.Qualified success is considered as reduction of the angle of deviation. Patients are examined 24 months later to assess outcome of treatment. | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05527015 -
Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near
|
Phase 3 | |
Completed |
NCT00746304 -
Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin
|
N/A | |
Completed |
NCT01460355 -
Comparison of Two Treatments for Strabismus Correction: Botulinum Toxin A Associated to Surgery and Surgery Alone
|
Phase 4 | |
Recruiting |
NCT06077682 -
Cycloplegic Refraction in Pediatric Patients With Esotropia
|
Phase 4 | |
Completed |
NCT02570555 -
Strabismus Surgery and Driving Ability
|
||
Active, not recruiting |
NCT00993174 -
Surgery for Esotropia Under Topical Anesthesia
|
N/A | |
Completed |
NCT01166503 -
Early Versus Delayed Surgery for Infantile Esotropia
|
||
Completed |
NCT00000121 -
The Prism Adaptation Study (PAS)
|
Phase 3 | |
Completed |
NCT04429659 -
Changes in Refractive Error in Patients With Both Partially Refractive Esotropia and Amblyopia
|
||
Recruiting |
NCT05615519 -
Validation of a Smartphone-based Intelligent Diagnosis and Measurement for Strabismus
|
||
Completed |
NCT00000163 -
Congenital Esotropia Observational Study (CEOS)
|
N/A | |
Recruiting |
NCT01616108 -
Bupivacaine Injection of Eye Muscles to Treat Strabismus
|
Phase 2/Phase 3 |